Topographic reductions in FEOBV binding correlated with domain-specific cognitive impairment, which is in line with the current literature reporting strong correlations between regional AChE activity and various neuropsychological measures for different cognitive functions (Haense et al., 2012). The gene discussed is ACHE; the disease is Cognitive impairment.